Cite
Shah SK, Kimmelman J, Lyerly AD, et al. Response-Evaluating human trials: FDA's role. Science. 2018;360(6395):1308-1309doi: 10.1126/science.aau0865.
Shah, S. K., Kimmelman, J., Lyerly, A. D., Lynch, H. F., Miller, F. G., Palacios, R., Pardo, C. A., & Zorrilla, C. (2018). Response-Evaluating human trials: FDA's role. Science (New York, N.Y.), 360(6395), 1308-1309. https://doi.org/10.1126/science.aau0865
Shah, S K, et al. "Response-Evaluating human trials: FDA's role." Science (New York, N.Y.) vol. 360,6395 (2018): 1308-1309. doi: https://doi.org/10.1126/science.aau0865
Shah SK, Kimmelman J, Lyerly AD, Lynch HF, Miller FG, Palacios R, Pardo CA, Zorrilla C. Response-Evaluating human trials: FDA's role. Science. 2018 Jun 22;360(6395):1308-1309. doi: 10.1126/science.aau0865. Epub 2018 Jun 21. PMID: 29930129.
Copy
Download .nbib